Anthem, Inc. (ANTM)
(Delayed Data from NYSE)
$261.70 USD
+0.11 (0.04%)
Updated May 3, 2019 04:00 PM ET
After-Market: $261.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$261.70 USD
+0.11 (0.04%)
Updated May 3, 2019 04:00 PM ET
After-Market: $261.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Sportsman's Warehouse, DXP Enterprises, Anthem and Centene Corp highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Sportsman's Warehouse, DXP Enterprises, Anthem and Centene Corp highlighted as Zacks Bull and Bear of the Day
Centene vs. Anthem: Which is a Better-Positioned Stock?
by Zacks Equity Research
Centene (CNC) and Anthem (ANTM) are poised to grow in the thriving health insurance industry. On comparative evaluation, we try to discover which is a more profitable bet based on fundamentals.
UnitedHealth to Aid Eligible Medicaid Members in Indiana
by Zacks Equity Research
UnitedHealth Group (UNH) intends to improve health outcomes of Medicaid members in Indiana, where it already has a strong presence.
Why Is Anthem (ANTM) Down 0.9% Since Last Earnings Report?
by Zacks Equity Research
Anthem (ANTM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Top Research Reports for Microsoft, Oracle & Medtronic
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Microsoft (MSFT), Oracle (ORCL) and Medtronic (MDT).
Zacks Industry Outlook Highlights: SEM, MOH, JYNT and HUM
by Zacks Equity Research
Zacks Industry Outlook Highlights: SEM, MOH, JYNT and HUM
Why Should You Retain Anthem (ANTM) Stock in Your Portfolio?
by Zacks Equity Research
Banking on an upbeat outlook and rising membership, Anthem (ANTM) holds immense potential to reap benefits for investors.
Here's Why Investors Should Bet on Select Medical Stock Now
by Zacks Equity Research
Select Medical (SEM) remains well-poised for growth on the back of improving revenues, strategic buyouts and impressive capital position.
3 Health Insurers That Surpass the S&P 500 Year to Date
by Srijita Guha
We zero in on three health insurers that have managed to outperform the broader index year to date, banking on core strength.
Top Stock Reports for Visa, GlaxoSmithKline & Anthem
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Visa (V), salesforce.com (CRM) and Anthem (ANTM).
Anthem, Quest Tie up to Improve Healthcare Across the US
by Zacks Equity Research
Anthem (ANTM) teams up with Quest in order to improve health outcomes to consumers with the help of their innovative solutions.
Here's Why You Should Add Humana (HUM) to Your Portfolio
by Zacks Equity Research
Riding high on its Medicare line of business and strategic initiatives, Humana (HUM) holds enough potential to reap benefits for investors.
Acadia Healthcare (ACHC) Q2 Earnings Top Estimates, Fall Y/Y
by Zacks Equity Research
Acadia Healthcare's (ACHC) Q2 earnings are hurt year over year by lower patient days and revenue per patient day, partly offset by decreased expenses.
6 Stocks Worth Buying Post Earnings
by Sejuti Banerjea
Nobody really knows how the pandemic will play out in the second half of the year, but here are a few stocks that look headed in the right direction.
Cigna (CI) Earnings Surpass Estimates in Q2, Improve Y/Y
by Zacks Equity Research
Cigna's (CI) Q2 earnings gain from a strong fundamental performance and reduced medical costs from delayed treatments amid the COVID-19 pandemic.
Company News for Jul 30, 2020
by Zacks Equity Research
Companies in the news are: ADP, ANTM, SHOP, ETN
Top Ranked Growth Stocks to Buy for July 30th
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, July 30th.
Anthem (ANTM) Q2 Earnings Surpass Estimates, Improve Y/Y
by Zacks Equity Research
Anthem's (ANTM) Q2 results reflect higher premium revenues and a solid contribution from Government business.
Big Tech Goes to Capitol Hill; Plus Q2 from BA, GE, SPOT & More
by Mark Vickery
What we may be seeing today is a preview of concerns of progressive lawmakers regarding anti-trust measures.
Earnings Data Deluge
by Zacks Equity Research
Earnings Data Deluge
Anthem (ANTM) Q2 Earnings Beat Estimates
by Zacks Equity Research
Anthem (ANTM) delivered earnings and revenue surprises of 4.90% and -0.87%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Top Ranked Growth Stocks to Buy for July 29th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 29th
5 Healthcare Stocks to Beat on Q2 Earnings Despite Coronavirus
by Zacks Equity Research
Companies across the healthcare sector experience a mixed impact from coronavirus. While some gain traction from a surge in virtual care, the rest suffers demand woes and supply-chain glitches.
Is a Surprise Coming for Anthem (ANTM) This Earnings Season?
by Zacks Equity Research
Anthem (ANTM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Teladoc (TDOC) Q2 Earnings to Gain From Coronavirus-Led Demand
by Zacks Equity Research
Teladoc Health (TDOC) Q2 earnings are likely to have gained from higher virtual health visits and membership growth from coronavirus-led demand.